Skip to content

Released Mar 8, 2018, before the open

10-K filed Mar 8, 2018, 67 days after period end · 0001144204-18-013474

Q4 2017 · 10-K
Revenue$3.32Mno prior Q4 2016 on file+24.6% vs Q3 2017
Net Income-$3.01MN/M vs Q4 2016N/M vs Q3 2017
EPS Diluted-$160.00N/M vs Q4 2016N/M vs Q3 2017
Operating Incomederived-$12,279,740N/M
Operating Cash Flowderived-$9,770,144N/M
Free Cash Flowderived-$10,132,029N/M
Margins · derived
Operating margin-370.4%
Net margin-90.7%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2017Q4 2016Q4 2015Q4 2014derived from reported figures
Revenue$3.32M———
Net Income-$3.01M-$11.55M-$7.75M-$6.23M
EPS Diluted-$160.00-$0.67-$0.45—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR